Follow the people · Insider
Arnold C. Hanish
Arnold C. Hanish files insider transactions with the SEC as a director of Decoy Therapeutics (DCOY). We hold 3 disclosed purchases and sales filed since 24 January 2006, 2 of them in the last 90 days.
- Files forDCOY
- Disclosed buys and sells3 in all, 2 in the last 90 days
- Last disclosure2 September 2026
Positions held
4 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 31 August 2026 — 31 August 2026Director · Decoy Therapeutics (DCOY)1 Form 4 line · source: SEC Form 4
- Filed 26 September 2012 — 27 August 2026Director · Omeros (OMER)31 Form 4 lines · source: SEC Form 4
- Filed 10 September 2019 — 30 December 2025Director · Salarius Pharmaceuticals (SLRX)21 Form 4 lines · source: SEC Form 4
- Filed 20 January 2006 — 29 August 2012Chief Accounting Officer · Lilly Eli & Co (LLY)27 Form 4 lines · source: SEC Form 4
Everything they disclosed
80 entries, newest first — one per disclosure report, one per Form 4 line- was granted 3,000 shares of Decoy TherapeuticsSEC Form 42 September 2026Common Stock · traded 31 August 2026 · filed 2 September 2026
- exercised options over 5,000 shares of OmerosSEC Form 428 August 2026Common Stock · traded 26 August 2026 · filed 28 August 2026
- ▼ sold on the open market 5,000 shares of OmerosSEC Form 428 August 2026Common Stock · traded 26 August 2026 · filed 28 August 2026
- exercised options over 2,500 shares of OmerosSEC Form 428 August 2026Common Stock · traded 27 August 2026 · filed 28 August 2026
- exercised options over 7,500 shares of OmerosSEC Form 428 August 2026Common Stock · traded 27 August 2026 · filed 28 August 2026
- ▼ sold on the open market 5,000 shares of OmerosSEC Form 428 August 2026Common Stock · traded 27 August 2026 · filed 28 August 2026
- ▼ sold on the open market 5,000 shares of OmerosSEC Form 428 August 2026Common Stock · traded 27 August 2026 · filed 28 August 2026
- exercised options over 5,000 shares of Omeros (a derivative holding)SEC Form 428 August 2026Stock Option (Right to Buy) · traded 26 August 2026 · filed 28 August 2026
- exercised options over 2,500 shares of Omeros (a derivative holding)SEC Form 428 August 2026Stock Option (Right to Buy) · traded 27 August 2026 · filed 28 August 2026
- exercised options over 7,500 shares of Omeros (a derivative holding)SEC Form 428 August 2026Stock Option (Right to Buy) · traded 27 August 2026 · filed 28 August 2026
- was granted 15,000 shares of Omeros (a derivative holding)SEC Form 422 June 2026Stock Option (Right to Buy) · traded 18 June 2026 · filed 22 June 2026
- ▼ sold on the open market 15 shares of Salarius PharmaceuticalsSEC Form 42 January 2026Common Stock · traded 30 December 2025 · filed 2 January 2026
- ▼ sold on the open market 12 shares of Salarius PharmaceuticalsSEC Form 42 January 2026Common Stock · traded 30 December 2025 · filed 2 January 2026
- ▼ sold on the open market 15 shares of Salarius PharmaceuticalsSEC Form 42 January 2026Common Stock · traded 30 December 2025 · filed 2 January 2026
- ▼ sold on the open market 12 shares of Salarius PharmaceuticalsSEC Form 42 January 2026Common Stock · traded 30 December 2025 · filed 2 January 2026
- ▲ bought on the open market 5,000 shares of Salarius PharmaceuticalsSEC Form 424 November 2025Common Stock · traded 20 November 2025 · filed 24 November 2025
- was granted 15,000 shares of Omeros (a derivative holding)SEC Form 41 July 2025Stock Option (Right to Buy) · traded 27 June 2025 · filed 1 July 2025
- was granted 15,000 shares of Omeros (a derivative holding)SEC Form 47 June 2024Stock Option (Right to Buy) · traded 6 June 2024 · filed 7 June 2024
- was granted 20,500 shares of Salarius Pharmaceuticals (a derivative holding)SEC Form 422 February 2024Stock Option (right to buy) · traded 20 February 2024 · filed 22 February 2024
- was granted 15,000 shares of Omeros (a derivative holding)SEC Form 427 June 2023Stock Option (Right to Buy) · traded 23 June 2023 · filed 27 June 2023
- exercised options over 5,000 shares of Omeros (a derivative holding)SEC Form 423 May 2023Stock Option (Right to Buy) · traded 22 May 2023 · filed 23 May 2023
- exercised options over 5,000 shares of OmerosSEC Form 423 May 2023Common Stock · traded 22 May 2023 · filed 23 May 2023
- ▼ sold on the open market 5,000 shares of OmerosSEC Form 423 May 2023Common Stock · traded 22 May 2023 · filed 23 May 2023
- was granted 1,440 shares of Salarius PharmaceuticalsSEC Form 45 January 2023Common Stock · traded 3 January 2023 · filed 5 January 2023
- was granted 7,500 shares of Omeros (a derivative holding)SEC Form 423 September 2022Stock Option (Right to Buy) · traded 21 September 2022 · filed 23 September 2022
- was granted 7,500 shares of Omeros (a derivative holding)SEC Form 422 June 2022Stock Option (Right to Buy) · traded 17 June 2022 · filed 22 June 2022
- ▲ bought on the open market 3,000 shares of Salarius PharmaceuticalsSEC Form 46 June 2022Common Stock · traded 25 November 2019 · filed 6 June 2022
- ▲ bought on the open market 4,350 shares of Salarius PharmaceuticalsSEC Form 46 June 2022Common Stock · traded 11 February 2020 · filed 6 June 2022
- ▲ bought on the open market 4,000 shares of Salarius PharmaceuticalsSEC Form 46 June 2022Common Stock · traded 21 August 2020 · filed 6 June 2022
- ▲ bought on the open market 28,000 shares of Salarius PharmaceuticalsSEC Form 46 June 2022Common Stock · traded 3 June 2022 · filed 6 June 2022
- was granted 7,500 shares of Omeros (a derivative holding)SEC Form 414 February 2022Stock Option (Right to Buy) · traded 11 June 2021 · filed 14 February 2022
- was granted 30,000 shares of Salarius Pharmaceuticals (a derivative holding)SEC Form 421 January 2022Stock Option (right to buy) · traded 20 January 2022 · filed 21 January 2022
- exercised options over 10,000 shares of Omeros (a derivative holding)SEC Form 49 September 2021Stock Option (Right to Buy) · traded 8 September 2021 · filed 9 September 2021
- exercised options over 10,000 shares of OmerosSEC Form 49 September 2021Common Stock · traded 8 September 2021 · filed 9 September 2021
- ▲ bought on the open market 7,000 shares of Salarius PharmaceuticalsSEC Form 411 August 2021Common Stock · traded 10 August 2021 · filed 11 August 2021
- was granted 30,000 shares of Salarius Pharmaceuticals (a derivative holding)SEC Form 44 December 2020Stock Option (right to buy) · traded 2 December 2020 · filed 4 December 2020
- ▲ bought on the open market 4,000 shares of Salarius PharmaceuticalsSEC Form 424 August 2020Common Stock · traded 21 August 2020 · filed 24 August 2020
- was granted 7,500 shares of Omeros (a derivative holding)SEC Form 49 June 2020Stock Option (Right to Buy) · traded 5 June 2020 · filed 9 June 2020
- was granted 6,000 shares of Salarius Pharmaceuticals (a derivative holding)SEC Form 425 March 2020Stock Option (right to buy) · traded 23 March 2020 · filed 25 March 2020
- ▲ bought on the open market 4,350 shares of Salarius Pharmaceuticals (a derivative holding)SEC Form 413 February 2020Warrants (right to buy) · traded 11 February 2020 · filed 13 February 2020
- ▲ bought on the open market 3,000 shares of Salarius PharmaceuticalsSEC Form 412 February 2020Common Stock · traded 25 November 2019 · filed 12 February 2020
- ▲ bought on the open market 4,350 shares of Salarius PharmaceuticalsSEC Form 412 February 2020Common Stock · traded 11 February 2020 · filed 12 February 2020
- ▲ bought on the open market 3,000 shares of Salarius PharmaceuticalsSEC Form 426 November 2019Common Stock · traded 25 November 2019 · filed 26 November 2019
- was granted 3,000 shares of Salarius Pharmaceuticals (a derivative holding)SEC Form 412 September 2019Stock Option (right to buy) · traded 10 September 2019 · filed 12 September 2019
- was granted 7,500 shares of Omeros (a derivative holding)SEC Form 411 June 2019Stock Option (Right to Buy) · traded 7 June 2019 · filed 11 June 2019
- was granted 7,500 shares of Omeros (a derivative holding)SEC Form 418 June 2018Stock Option (Right to Buy) · traded 15 June 2018 · filed 18 June 2018
- was granted 10,000 shares of Omeros (a derivative holding)SEC Form 416 June 2017Stock Option (right to buy) · traded 16 June 2017 · filed 16 June 2017
- was granted 7,500 shares of Omeros (a derivative holding)SEC Form 410 June 2016Stock Option (right to buy) · traded 9 June 2016 · filed 10 June 2016
- was granted 5,000 shares of Omeros (a derivative holding)SEC Form 427 May 2015Stock Option (right to buy) · traded 22 May 2015 · filed 27 May 2015
- was granted 5,000 shares of Omeros (a derivative holding)SEC Form 428 May 2014Stock Option (right to buy) · traded 23 May 2014 · filed 28 May 2014
- was granted 5,000 shares of Omeros (a derivative holding)SEC Form 428 May 2013Stock Option (Right to Buy) · traded 24 May 2013 · filed 28 May 2013
- ▲ bought on the open market 2,000 shares of OmerosSEC Form 43 January 2013Common Stock · traded 3 January 2013 · filed 3 January 2013
- gave away 136 shares of Lilly Eli & CoSEC Form 430 October 2012Common Stock · traded 29 August 2012 · filed 30 October 2012
- was granted 15,000 shares of Omeros (a derivative holding)SEC Form 428 September 2012Stock Option (Right to Buy) · traded 26 September 2012 · filed 28 September 2012
- gave away 238 shares of Lilly Eli & CoSEC Form 421 May 2012Common Stock · traded 2 May 2012 · filed 21 May 2012
- ▼ sold on the open market 1,295 shares of Lilly Eli & CoSEC Form 421 May 2012Common Stock · traded 18 May 2012 · filed 21 May 2012
- was granted 2,235 shares of Lilly Eli & CoSEC Form 42 February 2012Common Stock · traded 26 January 2012 · filed 2 February 2012
- was granted 2,210 shares of Lilly Eli & CoSEC Form 430 January 2012Common Stock · traded 26 January 2012 · filed 30 January 2012
- gave away 243 shares of Lilly Eli & CoSEC Form 418 May 2011Common Stock · traded 11 May 2011 · filed 18 May 2011
- ▼ sold on the open market 3,378 shares of Lilly Eli & CoSEC Form 418 May 2011Common Stock · traded 17 May 2011 · filed 18 May 2011
- gave away 232 shares of Lilly Eli & CoSEC Form 431 January 2011Common Stock · traded 4 March 2010 · filed 31 January 2011
- was granted 3,415 shares of Lilly Eli & CoSEC Form 427 January 2011Common Stock · traded 25 January 2011 · filed 27 January 2011
- was granted 3,378 shares of Lilly Eli & CoSEC Form 428 January 2010Common Stock · traded 26 January 2010 · filed 28 January 2010
- gave away 187 shares of Lilly Eli & CoSEC Form 423 November 2009Common Stock · traded 5 August 2009 · filed 23 November 2009
- ▼ sold on the open market 2,673 shares of Lilly Eli & CoSEC Form 423 November 2009Common Stock · traded 20 November 2009 · filed 23 November 2009
- had shares withheld for tax on 463 shares of Lilly Eli & CoSEC Form 429 April 2009Common Stock · traded 27 April 2009 · filed 29 April 2009
- was granted 1,636 shares of Lilly Eli & CoSEC Form 429 January 2009Common Stock · traded 27 January 2009 · filed 29 January 2009
- was granted 2,579 shares of Lilly Eli & CoSEC Form 429 January 2008Common Stock · traded 25 January 2008 · filed 29 January 2008
- gave away 125 shares of Lilly Eli & CoSEC Form 43 May 2007Common Stock · traded 26 April 2007 · filed 3 May 2007
- ▼ sold on the open market 1,565 shares of Lilly Eli & CoSEC Form 43 May 2007Common Stock · traded 2 May 2007 · filed 3 May 2007
- had shares withheld for tax on 463 shares of Lilly Eli & CoSEC Form 41 May 2007Common Stock · traded 27 April 2007 · filed 1 May 2007
- gave away 115 shares of Lilly Eli & CoSEC Form 412 February 2007Common Stock · traded 26 June 2006 · filed 12 February 2007
- was granted 1,295 shares of Lilly Eli & CoSEC Form 419 January 2007Common Stock · traded 17 January 2007 · filed 19 January 2007
- exercised options over 1,250 shares of Lilly Eli & Co (a derivative holding)SEC Form 419 September 2006Employee stock option 10/96 (right to buy) · traded 18 September 2006 · filed 19 September 2006
- exercised options over 1,250 shares of Lilly Eli & CoSEC Form 419 September 2006Common Stock · traded 18 September 2006 · filed 19 September 2006
- ▼ sold on the open market 1,250 shares of Lilly Eli & CoSEC Form 419 September 2006Common Stock · traded 18 September 2006 · filed 19 September 2006
- was granted 4,518 shares of Lilly Eli & Co (a derivative holding)SEC Form 414 February 2006Employee stock option 2/06 (right to buy) · traded 10 February 2006 · filed 14 February 2006
- exercised options over 1,250 shares of Lilly Eli & Co (a derivative holding)SEC Form 48 February 2006Employee stock option 10/96 (right to buy) · traded 6 February 2006 · filed 8 February 2006
- exercised options over 1,250 shares of Lilly Eli & CoSEC Form 48 February 2006Common Stock · traded 6 February 2006 · filed 8 February 2006
- was granted 1,036 shares of Lilly Eli & CoSEC Form 424 January 2006Common Stock · traded 20 January 2006 · filed 24 January 2006
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.